Paul Williams

All filings by Paul Williams on record concern Emergent BioSolutions Inc. In total, 2 filings cover trades dated from 1 July 2026 to 1 October 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 1 October 2026: a transaction of €17k, in Emergent BioSolutions Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.